The findings help explain why some people appear far more likely than others to transmit respiratory viruses and offer new insight into how influenza spreads through the air.
By simplifying complex cardiac anatomy through real-time AI labeling, T-Mode™ Heart removes the training barrier to ultrasound adoption for family physicians and medical students.
Built for high reliability, world’s only lumenless defibrillation lead approved for placement in the left bundle branch area
This breakthrough could lead to next-generation medical tools that track disease, guide treatment and monitor the body in real time
Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy.
Growing evidence has demonstrated that low-dose radiation can target inflammation and reduce pain for osteoarthritis patients.
Powerful brain imaging has helped uncover why people with post-traumatic stress disorder (PTSD) who engage in negative self-talk may be struggling with the first line of treatment. The discovery, published in Nature Mental Health, sheds new light as to why underlying brain mechanisms mean some therapies potentially work for some people and not others, and could guide the development of more targeted treatments for PTSD.
Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, Cornell Tech, Cornell Ann S. Bowers College of Computing and Information Science, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian—offers the prospect of better care for many thousands of patients who may be overlooked due to the difficulty of diagnosing their condition.
LivaNova (Nasdaq: LIVN)+ announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system for sleep apnea.
There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial intelligence to quantitatively measure for the first time the extent to which it reduces skin lesions.